Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine for prevention of filgrastim-induced bone pain in patients with cancer receiving chemotherapy
PACTR202608847016612Recruiting
- Sponsor
- NAFISAH MAMMAN MOHAMMED
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of loratadine in ostealgia (2 arms), sponsored by NAFISAH MAMMAN MOHAMMED. Primary endpoint: Incidence of filgrastim-induced bone pain. Started Jan 2026; status: recruiting.
02
Drugs
loratadine
03
Conditions
ostealgia
Beyond the preview
Go deeper on PACTR202608847016612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608847016612.